These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 11369469

  • 1. Doxorubicin-induced persistent oxidative stress to cardiac myocytes.
    Zhou S, Palmeira CM, Wallace KB.
    Toxicol Lett; 2001 May 19; 121(3):151-7. PubMed ID: 11369469
    [Abstract] [Full Text] [Related]

  • 2. Cardioselective and cumulative oxidation of mitochondrial DNA following subchronic doxorubicin administration.
    Serrano J, Palmeira CM, Kuehl DW, Wallace KB.
    Biochim Biophys Acta; 1999 Apr 21; 1411(1):201-5. PubMed ID: 10216166
    [Abstract] [Full Text] [Related]

  • 3. Preferential oxidation of cardiac mitochondrial DNA following acute intoxication with doxorubicin.
    Palmeira CM, Serrano J, Kuehl DW, Wallace KB.
    Biochim Biophys Acta; 1997 Aug 22; 1321(2):101-6. PubMed ID: 9332499
    [Abstract] [Full Text] [Related]

  • 4. Dietary vitamin E decreases doxorubicin-induced oxidative stress without preventing mitochondrial dysfunction.
    Berthiaume JM, Oliveira PJ, Fariss MW, Wallace KB.
    Cardiovasc Toxicol; 2005 Aug 22; 5(3):257-67. PubMed ID: 16244371
    [Abstract] [Full Text] [Related]

  • 5. Oxymatrine Ameliorates Doxorubicin-Induced Cardiotoxicity in Rats.
    Zhang YY, Yi M, Huang YP.
    Cell Physiol Biochem; 2017 Aug 22; 43(2):626-635. PubMed ID: 28946137
    [Abstract] [Full Text] [Related]

  • 6. Nitric oxide and oxidative stress in brain and heart of normal rats treated with doxorubicin: role of aminoguanidine.
    Abd El-Gawad HM, El-Sawalhi MM.
    J Biochem Mol Toxicol; 2004 Aug 22; 18(2):69-77. PubMed ID: 15122648
    [Abstract] [Full Text] [Related]

  • 7. Doxorubicin induces cardiomyocyte dysfunction via a p38 MAP kinase-dependent oxidative stress mechanism.
    Wold LE, Aberle NS, Ren J.
    Cancer Detect Prev; 2005 Aug 22; 29(3):294-9. PubMed ID: 15936597
    [Abstract] [Full Text] [Related]

  • 8. The effect of doxorubicin and its analogue mitoxantrone on cardiac muscle and on serum lipids: an experimental study.
    Koutinos G, Stathopoulos GP, Dontas I, Perrea-Kotsarelis D, Couris E, Karayannacos PE, Deliconstantinos G.
    Anticancer Res; 2002 Aug 22; 22(2A):815-20. PubMed ID: 12014656
    [Abstract] [Full Text] [Related]

  • 9. Editor's Highlight: The Altered DNA Methylome of Chronic Doxorubicin Exposure in Sprague Dawley Rats.
    Nordgren KKS, Hampton M, Wallace KB.
    Toxicol Sci; 2017 Oct 01; 159(2):470-479. PubMed ID: 28962528
    [Abstract] [Full Text] [Related]

  • 10. Sesamin ameliorates doxorubicin-induced cardiotoxicity: involvement of Sirt1 and Mn-SOD pathway.
    Su S, Li Q, Liu Y, Xiong C, Li J, Zhang R, Niu Y, Zhao L, Wang Y, Guo H.
    Toxicol Lett; 2014 Jan 13; 224(2):257-63. PubMed ID: 24211423
    [Abstract] [Full Text] [Related]

  • 11. Curcumin attenuates doxorubicin-induced cardiotoxicity via suppressing oxidative stress and preventing mitochondrial dysfunction mediated by 14-3-3γ.
    He H, Luo Y, Qiao Y, Zhang Z, Yin D, Yao J, You J, He M.
    Food Funct; 2018 Aug 15; 9(8):4404-4418. PubMed ID: 30063064
    [Abstract] [Full Text] [Related]

  • 12. Klotho Improves Cardiac Function by Suppressing Reactive Oxygen Species (ROS) Mediated Apoptosis by Modulating Mapks/Nrf2 Signaling in Doxorubicin-Induced Cardiotoxicity.
    Zhu H, Gao Y, Zhu S, Cui Q, Du J.
    Med Sci Monit; 2017 Nov 06; 23():5283-5293. PubMed ID: 29107939
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Oxidative stress and myocardial gene alterations associated with Doxorubicin-induced cardiotoxicity in rats persist for 2 months after treatment cessation.
    Richard C, Ghibu S, Delemasure-Chalumeau S, Guilland JC, Des Rosiers C, Zeller M, Cottin Y, Rochette L, Vergely C.
    J Pharmacol Exp Ther; 2011 Dec 06; 339(3):807-14. PubMed ID: 21934029
    [Abstract] [Full Text] [Related]

  • 16. Plantainoside D protects adriamycin-induced apoptosis in H9c2 cardiac muscle cells via the inhibition of ROS generation and NF-kappaB activation.
    Kim DS, Woo ER, Chae SW, Ha KC, Lee GH, Hong ST, Kwon DY, Kim MS, Jung YK, Kim HM, Kim HK, Kim HR, Chae HJ.
    Life Sci; 2007 Jan 02; 80(4):314-23. PubMed ID: 17034819
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Persistent alterations to the gene expression profile of the heart subsequent to chronic Doxorubicin treatment.
    Berthiaume JM, Wallace KB.
    Cardiovasc Toxicol; 2007 Jan 02; 7(3):178-91. PubMed ID: 17901561
    [Abstract] [Full Text] [Related]

  • 19. Targeted disruption of p53 attenuates doxorubicin-induced cardiac toxicity in mice.
    Shizukuda Y, Matoba S, Mian OY, Nguyen T, Hwang PM.
    Mol Cell Biochem; 2005 May 02; 273(1-2):25-32. PubMed ID: 16013437
    [Abstract] [Full Text] [Related]

  • 20. Elevated glutathione is not sufficient to protect against doxorubicin-induced nuclear damage in heart in multidrug resistance-associated protein 1 (Mrp1/Abcc1) null mice.
    Deng J, Coy D, Zhang W, Sunkara M, Morris AJ, Wang C, Chaiswing L, St Clair D, Vore M, Jungsuwadee P.
    J Pharmacol Exp Ther; 2015 Nov 02; 355(2):272-9. PubMed ID: 26354996
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.